Host-pathogen Interactome Mapping for HTLV-1 and -2 Retroviruses

Nicolas Simonis,Jean-François Rual,Irma Lemmens,Mathieu Boxus,Tomoko Hirozane-Kishikawa,Jean-Stéphane Gatot,Amélie Dricot,Tong Hao,Didier Vertommen,Sébastien Legros,Sarah Daakour,Niels Klitgord,Maud Martin,Jean-François Willaert,Franck Dequiedt,Vincent Navratil,Michael E Cusick,Arsène Burny,Carine Van Lint,David E Hill,Jan Tavernier,Richard Kettmann,Marc Vidal,Jean-Claude Twizere
DOI: https://doi.org/10.1186/1742-4690-9-26
2012-01-01
Retrovirology
Abstract:BACKGROUND:Human T-cell leukemia virus type 1 (HTLV-1) and type 2 both target T lymphocytes, yet induce radically different phenotypic outcomes. HTLV-1 is a causative agent of Adult T-cell leukemia (ATL), whereas HTLV-2, highly similar to HTLV-1, causes no known overt disease. HTLV gene products are engaged in a dynamic struggle of activating and antagonistic interactions with host cells. Investigations focused on one or a few genes have identified several human factors interacting with HTLV viral proteins. Most of the available interaction data concern the highly investigated HTLV-1 Tax protein. Identifying shared and distinct host-pathogen protein interaction profiles for these two viruses would enlighten how they exploit distinctive or common strategies to subvert cellular pathways toward disease progression.RESULTS:We employ a scalable methodology for the systematic mapping and comparison of pathogen-host protein interactions that includes stringent yeast two-hybrid screening and systematic retest, as well as two independent validations through an additional protein interaction detection method and a functional transactivation assay. The final data set contained 166 interactions between 10 viral proteins and 122 human proteins. Among the 166 interactions identified, 87 and 79 involved HTLV-1 and HTLV-2 -encoded proteins, respectively. Targets for HTLV-1 and HTLV-2 proteins implicate a diverse set of cellular processes including the ubiquitin-proteasome system, the apoptosis, different cancer pathways and the Notch signaling pathway.CONCLUSIONS:This study constitutes a first pass, with homogeneous data, at comparative analysis of host targets for HTLV-1 and -2 retroviruses, complements currently existing data for formulation of systems biology models of retroviral induced diseases and presents new insights on biological pathways involved in retroviral infection.
What problem does this paper attempt to address?